Item 9 Labs Corp.
Item 9 Labs Corp. (INLB) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
inlb · pe ratio · data through Sep 30, 2022
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Item 9 Labs Corp. (INLB) measures how much investors pay for each dollar of the company's trailing earnings. INLB's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.33.
Source: FMP · /ratios-ttm · /analyst-estimates · 2022-09-30
PE Ratio History
2011 – 2022 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Item 9 Labs Corp.You INLB | $0M | N/A | — | -$0.33 |
 Biome Grow Inc. BIOIF | $0M | N/A | — | -$0.10 |
 Cannabis Global, Inc. CBGL | $0M | N/A | — | -$0.00 |
 Green Rain Energy Holdings Inc. GREH | $0M | N/A | — | -$0.00 |
 Hero Technologies Inc. HENC | $0M | N/A | — | -$0.00 |
 Isodiol International Inc. ISOLF | $0M | N/A | — | -$2.35 |
 Jack Nathan Medical Corp. JNHMF | $1M | 1.40x | — | $0.03 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2022-09-30Latest FY2022 | — | $-0.33 | — | |
2021-09-30 FY2021 | — | $-0.14 | — | |
2020-09-30 FY2020 | — | $-0.20 | — | |
2019-09-30 FY2019 | — | $-0.17 | — | |
2018-09-30 FY2018 | — | $-0.23 | — | |
2017-09-30 FY2017 | — | $-0.04 | — | |
2016-09-30 FY2016 | — | $-0.82 | — | |
2015-09-30 FY2015 | — | $-1.43 | — | |
2014-09-30 FY2014 | — | $-6.87 | — | |
2013-09-30 FY2013 | — | $-1.94 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Item 9 Labs Corp. (INLB) measures how much investors pay for each dollar of the company's trailing earnings. INLB's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.33.
Frequently asked questions
INLB pe ratio · 6 questionsINLB's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.00 and TTM EPS of -$0.33. Data sourced from Financial Modeling Prep via INLB's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Item 9 Labs Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09